Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2000, p. 9331-9336, Vol. 20, No. 24
Institute for Molecular Bioscience,
University of Queensland, Brisbane 4072, Australia,1 and Samuel Lunenfeld
Research Institute, Mount Sinai Hospital, Toronto, Canada M5G
1X52
Received 21 June 2000/Returned for modification 21 August
2000/Accepted 11 September 2000
We have previously shown that Sox18 is expressed in
developing vascular endothelium and hair follicles during mouse
embryogenesis and that point mutations in Sox18 are the
underlying cause of cardiovascular and hair follicle defects in
ragged (Ra) mice. Here we describe the analysis
of Sox18 Members of the SOX
(Sry-type HMG box) gene family encode transcription factors
that have a wide range of roles in development (reviewed by Wegner
[39]). SOX proteins bind DNA in a sequence-specific manner, and a heptameric SOX consensus binding motif,
5'-(A/T)(A/T)CAA(A/T)G-3', has been identified
(12). Most tissues and cell types express at least one
SOX gene at one stage or another of their development (39). Moreover, many cell types or tissues express more than one SOX gene at certain times (6, 20, 22, 36,
37).
Gene targeting experiments with the mouse have assigned vital roles in
development to numerous SOX genes: Sox1 in lens
formation (28), Sox4 in cardiac tract outflow
formation and B-lymphocyte development (32), and
Sox9 in chondrogenesis (3). This has been
reinforced by mutations in human SOX genes: SRY
mutations in sex reversal and gonadal dysgenesis (2, 11, 13,
15), SOX9 mutations in the bone dysmorphogenesis and
sex reversal syndrome campomelic dysplasia (9, 38), and
SOX10 mutations in various neurocristopathies such as
Waardenberg-Shah syndrome 4 (30) and the Yemenite deaf-blind
hypopigmentation syndrome (4). Further, such mutations have
revealed an importance of dosage for some SOX genes, with
deletion or mutation of one allele of SOX9 or
SOX10 resulting in a disease phenotype (9, 30,
38).
We have previously shown that point mutations in Sox18 are
the underlying cause of profound cardiovascular and hair follicle defects in ragged (Ra) mice (29).
Ra heterozygotes have thin, ragged coats comprised of guard
hairs but lacking the later-forming auchenes and zigzags
(5). Ra homozygotes, however, almost completely lack vibrissae and coat hairs, display generalized edema and cyanosis, and rarely survive past weaning (5). In a more severe
Ra mutation, RaOp, heterozygotes
typically show a phenotype similar to that of Ra
homozygotes, whereas RaOp homozygotes die by
11.5 days postcoitus (dpc) (10, 24). The coat defects in
Ra mice are due to a reduction in the total number of hair
follicles, with the later-forming follicles being the most affected
(33).
In Ra mice, the Sox18 mutations lead to an intact
DNA-binding domain but a nonfunctional trans-activation
domain (29). Given the semidominant nature of the
Ra mutations (5, 10), it was not clear whether
the phenotype of Ra mice was due to haploinsufficiency of
Sox18, as has been described for other SOX genes,
or whether there was a dominant-negative effect of the mutant SOX18
protein. To address this question, we produced mice null for
Sox18, and we describe here their production and analysis.
Targeting of Sox18 and production of chimeric
mice.
Overlapping genomic clones hybridizing to Sox18
were obtained from a
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mice Null for Sox18 Are Viable and
Display a Mild Coat Defect

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
mice produced by gene targeting.
Despite the profound defects seen in Ra mice,
Sox18
/
mice have no obvious cardiovascular
defects and only a mild coat defect with a reduced proportion of zigzag
hairs. A reduction in the amount of pheomelanin pigmentation in hair
shafts was also observed; later-forming hair follicles showed a reduced
subapical pheomelanin band, giving Sox18
/
mice a slightly darker appearance than Sox18+/+
and Sox18+/
siblings.
Sox18
/
mice are viable and fertile and show
no difference in the ability to thrive relative to littermates. Because
of the mild effect of the mutation on the phenotype of
Sox18
/
mice, we conclude that the
semidominant nature of the Ra mutations is due to a
trans-dominant negative effect mediated by the mutant SOX18
proteins rather than haploinsufficiency as has been observed for other
SOX genes. Due to the similarity of SOX18 to other subgroup F SOX proteins, SOX7 and
17, and the overlap in expression of these
genes, functional redundancy amongst these SOX proteins could also
account for the mild phenotype of Sox18
/
mice.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
phage library constructed from 129/Sv genomic
DNA which was partially digested with MboI and cloned into
the BamHI sites of
DashII vector (Philippe Soriano,
personal communication). Four overlapping clones were mapped using
restriction digests and Southern hybridization. The 1.8-kb, 5' flanking
fragment was generated by high-fidelity PCR from a genomic clone to
incorporate XbaI sites and facilitate subcloning. The 3'
flanking arm was an 11-kb fragment subcloned from a genomic clone. The
3' and 5' flanking sequences were cloned into a plasmid, pLoxPneo-1,
that contains a neomycin resistance cassette
(neor) driven by the PGK-1 promoter, all flanked
by directional LoxP sites (A.N., unpublished data). The LoxP sites were
included to allow the excision of intervening sequence in the presence
of cre recombinase (1). A promoterless
lacZ reporter cassette (19) was subcloned into
the targeting vector so that an in-frame SOX18-
-galactosidase
fusion protein would be produced to facilitate gene expression studies.
A thymidine kinase cassette (25) was used in the targeting
vector for counterselection in embryonic stem (ES) cells.
Genotyping of mice and embryos. Mice and embryos used in this study were genotyped by genomic DNA Southern hybridization (as described above for screening ES cell clones) or by PCR on genomic DNA prepared from ear punches or tail clips as described by Joyner (16). To detect the targeted allele, the neor-specific primers neoR (5'-CAA GCT CTT CAG CAA TAT CAC G-3') and neoF (5'-ATC TCC TGT CAT CTC ACC TTG C-3') were used. To detect the wild-type Sox18 allele, the primers Sox18-Box A (5'-CCA ACG TCT CGC CCA CCT CG-3') and Sox18-Box B (5'-GCC GCT TCT CCG CCG TGT TC-3') were used. Mutant embryos were always genotyped by PCR amplification from a portion of the yolk sac or allantois that had been well rinsed in a large volume of phosphate-buffered saline.
RT-PCR analysis. cDNA was produced in a reaction mixture containing 1 µg of RNA, 1× "first-strand" buffer (Gibco BRL; 50 mM Tris-HCl [pH 8.3], 75 mM KCl, 3 mM MgCl2), 375 µM deoxynucleoside triphosphates, 100 mM dithiothreitol, 500 ng of pd(N)6 random primers (Pharmacia), 200 U of Moloney murine leukemia virus reverse transcriptase (RT) (Gibco BRL), and RNase-free MilliQ water in a total volume of 30 µl. The reaction mixture was incubated at 42°C for 1 h, and 5 µl was used in a 25-µl PCR. The primer pairs used were as follows: for detection of neor transcripts, neoR (5'-CAA GCT CTT CAG CAA TAT CAC G-3') and neoF (5'-ATC TCC TGT CAT CTC ACC TTG C-3'); for lacZ transcripts, LacZ A (5'-CAG CAC ATC CCC CTT TCG CC-3') and LacZ B (5'-CCA ACG CAG CAC CAT CAC CG-3'); for the 3' portion of Sox18 downstream of the lacZ reporter and neor (encoding the trans-activation domain), Sox18-3' A (5'-GGC TTT CCG GGC ACC CTA TG-3') and Sox18-3' B (5'-AAG CGG TGG AGG GCA AGG AC-3'); for the region of Sox18 encoding the HMG box, Sox18-Box A (5'-CCA ACG TCT CGC CCA CCT CG-3') and Sox18-Box B (5'-GCC GCT TCT CCG CCG TGT TC-3'); for the 5' region of Sox18 upstream of the lacZ reporter and neor, Sox18-5' A (5'-TGA GAC AGT GGG AGC AGA TGG-3') and Sox18-5' B (5'-GCA AAG CCA AGT ACG GAG GTC 3'); and for GAPDH transcripts, GAPDH F (5'-TCG GTG TGA ACG GAT TTG-3') and GAPDH R (5'-ATT CTC GGC CTT GAC TGT-3').
Expression studies. Whole-mount immunohistochemistry was done using an anti-PECAM-1 (CD31) antibody (Pharmingen, San Diego, Calif.) at a dilution of 1/250, using standard techniques described elsewhere (40).
Analysis of the coats of Sox18
/
mice.
The coat qualities of adult
Sox18
/
and control mice were analyzed by
visual inspection, and mice were photographed with standard color-reversal film. To survey the relative abundance of the various hair types among the coats of Sox18
/
and
control mice, hairs were plucked in bunches from the middorsa of adult
mice, typically 3 months of age. A broad pair of forceps (Millipore)
was used to obtain three samples from each test subject. A dissecting
microscope was used to count the hairs of each type according to the
mouse hair classification of Dry (7). The total number of
hairs from each subject varied between 160 and 380 in order to give a
statistically valid sampling of hair types. Photography of mouse hairs
was performed on a dissecting stereomicroscope (Leica MZ8) with
bright-field illumination after hairs were dry mounted on a microscope
slide with a coverslip and nail polish.
| |
RESULTS |
|---|
|
|
|---|
Targeting of the Sox18 gene.
The gene targeting
strategy was designed to produce mice null for Sox18 by
removing the region encoding the HMG box (DNA-binding domain) and
replacing it with a lacZ reporter cassette and a
neor cassette, both of which contain
transcription termination sequences. Southern blot analysis of genomic
DNA from Sox18
/
and
Sox18+/
mice confirmed that the
Sox18 locus had been targeted as expected, with the region
encoding the HMG box being removed and replaced by the lacZ
and neor cassettes (Fig.
1). However, analysis of
Sox18
/
and Sox18+/
embryos at 9.5 dpc, a stage when Sox18 is expressed strongly in the developing vascular system (29), failed to show
-galactosidase staining (data not shown). Sequencing of the
targeting vector confirmed that an in-frame fusion protein comprising
the N-terminal 89 amino acids of SOX18 and
-galactosidase (data not
shown) should have been produced. It is unclear why the lacZ
reporter cassette is nonfunctional in Sox18
/
and Sox18+/
embryos, though one possibility is
that the N-terminal 89 amino acids of SOX18 interfered with the
enzymatic activity of
-galactosidase.
|
RT-PCR analysis of the mutant transcript.
To analyse which
transcripts were produced from the targeted Sox18 locus,
RT-PCR was conducted on RNA from mutant and wild-type embryos. RT-PCR
analysis confirmed that there were no transcripts from the HMG box
domain-encoding region from the targeted allele (Fig.
2). As can be seen in Fig. 2, the pattern
of neor and lacZ expression was also
as expected, being present only in embryos carrying a targeted locus.
Analysis of the region encoding the trans-activation domain
(downstream of the lacZ and neor
cassettes), however, revealed that this portion of the gene was transcribed from both wild-type and targeted loci. In addition, a
portion of the coding region 5' to the lacZ and
neor cassettes, and common to both wild-type and
targeted loci, appeared to be transcribed only from the targeted locus.
It is known that this region is transcribed under normal circumstances
and that mRNA secondary structure does not interfere with reverse
transcription in this region, since this sequence is present in cDNA
clones derived by reverse transcription (8). We are
therefore unable to explain the lack of expression of the 5' region of
Sox18 observed in these experiments.
|
Sox18
/
mice are viable and
fertile.
Germ line transmission of the targeted Sox18
allele was achieved by breeding male chimeras derived from the two
independently targeted ES cell lines. Genotyping of litters from
intercrosses of F1 Sox18+/
heterozygotes revealed that Sox18
/
mice
appeared in Mendelian ratios. Breeding studies also indicated that the
Sox18
/
mice could interbreed, proving that
they were fertile (data not shown).
Anatomical analysis of Sox18
/
embryos.
As Sox18
/
mice appeared to
have no reduced viability or fertility, there were likely to be no
major cardiovascular defects associated with the targeted mutation.
Immunohistochemistry using an antibody to the vascular endothelium
marker PECAM-1 (CD31) revealed that there were no major defects in the
gross morphology of the hearts of Sox18
/
embryos (Fig. 3). In addition, the dorsal aortae, intersomitic vessels,
and vessels of the limb bud mesenchyme appeared grossly normal (Fig.
3). There did not appear to be any
hemorrhage or edema in these embryos at 9.5 dpc. Likewise, at 14.5 dpc,
no gross abnormalities, hemorrhage, or edema was detected in
Sox18
/
embryos (Fig.
4). Furthermore, vibrissa follicles in
Sox18
/
embryos had developed in numbers
comparable to those in littermates at the appropriate stage (Fig. 4).
|
|
Growth rate of Sox18
/
mice.
As a
general index of the well-being of Sox18
/
mice, and to try to detect any subtle difference in the physiologies of
these mice, their growth rate relative to that of littermate controls was measured in terms of total weight. This analysis was performed using male littermates from both targeted lines. Over a 2-month period,
no statistically significant difference was observed between Sox18
/
mice and
Sox18+/
and Sox18+/+
littermate controls at any stage (data not shown).
Coat color of Sox18
/
mice.
Segregation of alleles of coat color genes among the stock of
Sox18
/
mice was observed due to the mixed
genetic background of CD1 and 129/Sv. This facilitated the analysis of
coat formation, with numerous pigmentation phenotypes, including
albino, chinchilla, and agouti, appearing in the stock of
Sox18
/
mice.
Sox18
/
mice had a slightly darker appearance
than littermate controls on agouti (Fig.
5) and chinchilla (data not shown)
backgrounds. Otherwise, no visible difference was detected in the coats
of Sox18
/
mice. Microscopic examination of
the various hair types was conducted to further analyze the basis of
the different coat pigmentation of Sox18
/
mice. Again, this was done using mice with an agouti phenotype to
facilitate examination of the subapical pheomelanin band typical of
many agouti hairs. Examples of the four main types of pelage hairs
the
guard hairs, awls, auchenes, and zigzags
appeared morphologically normal, though there was a difference in the pigmentation of many hair
types between Sox18
/
mice and littermate
controls (Fig. 6). Guard hairs, which
never have a subapical pheomelanin band, appeared the same in
Sox18
/
mice and controls upon microscopic
examination (Fig. 6). Some awls from wild-type mice showed a subapical
pheomelanin band, though most, like all those from
Sox18
/
mice, did not. Many auchenes and
zigzags from Sox18
/
mice showed either a
reduced or completely absent pheomelanin band.
|
|
Hair formation in Sox18
/
mice.
As
some hair types are malformed and underrepresented in Ra
mice, namely the later-forming auchenes and zigzag hairs, we conducted a survey of the proportion of pelage hair types amongst
Sox18
/
mice. From Fig.
7 it can be inferred that the proportion
of guard hairs and awls was not significantly different between
Sox18
/
and littermate controls. There was a
marked difference, however, in the proportion of zigzag hairs, which
represented 56% of total hairs in wild-type mice and 36% in
Sox18
/
mice. It is worth noting that
vibrissae and vibrissa follicles seemed normal at all stages in
Sox18
/
embryos and mice (Fig. 4 and 5).
|
| |
DISCUSSION |
|---|
|
|
|---|
The inactivation of Sox18 by gene targeting has
demonstrated that this gene is not vital for embryogenesis. The mild
phenotype observed in Sox18
/
mice is in
stark contrast to that resulting from the Ra mutations. Given the surprisingly mild effect of the mutation on the phenotype of
the Sox18
/
mice, it was important to show
that the targeted mutation was indeed a null mutation by genomic
Southern blot. This analysis confirmed that the targeting event had
removed the portion of the gene encoding the HMG box domain and
replaced it with a lacZ reporter and a
neor cassette. It remains formally possible that
the residual, expressed, C-terminal region of SOX18, containing the
trans-activation domain, may retain some function, perhaps
by interaction with another protein in a manner that does not depend on
DNA binding. However, given the known importance of HMG domain-mediated
DNA binding for the function of other SOX transcription factors, such
as SRY and SOX9, it is reasonable to assume that removal of the HMG box destroys the function of the SOX18 protein.
Despite the expression pattern of Sox18 during embryogenesis
and the finding that Sox18 mutations in Ra mice
have a profound effect on cardiovascular and hair follicle development
(29), Sox18 does not appear to be essential for
development of these tissues. That the weight of
Sox18
/
mice is similar to that of
littermates is also in contrast to the situation with Ra
mice. Shortly after birth, Ra mice are heavier than normal
because of a buildup of fluid due to edema and hemorrhage, which soon
dissipates. More significantly, however, they grow more slowly than
their littermates (5). The normal growth rate of
Sox18
/
mice indicates that the physiology of
these mice under normal conditions is not unduly affected by the
targeted mutation.
In the light of the contrasting phenotypes of Ra and
Sox18
/
mice, it appears that the mutant
SOX18 proteins in Ra mice are acting in a
trans-dominant negative manner. It is tempting to speculate
that the mutant SOX18 in Ra mice interferes with another SOX
protein(s), which in the presence of the targeted null mutation manages
to almost fully compensate for the absence of a fully functional SOX18.
One can readily envisage a situation whereby the mutant SOX18 protein
from Ra mice, which have an intact HMG box but have lost the
ability to trans-activate, competes with wild-type SOX18
(and any other SOX protein present with a similar target binding site)
and prevents the activation of transcription of the target gene. This
hypothesis is supported by the evidence that SOX proteins display
affinity for similar binding sites (39) and that, at least
in some tissue types, Sox18 is coexpressed with
Sox7 and Sox17 (see below). Conversely, it is
possible that the mutant SOX18 proteins from Ra mice have
gain-of-function mutations and that they interfere with some other
aspects of the cell's transcription machinery. Analysis of the
phenotype of compound heterozygotes from a cross of Ra/+ and
Sox18
/
mice would be informative with regard
to the mode of action of these mutant proteins and might shed some
light on the nature of SOX proteins. These experiments are in progress.
Like Ra mice, Sox18
/
mice are
most affected in the later-forming hair types, with a reduction in the
number of zigzags. Also like Ra mice,
Sox18
/
mice are darker than their
littermates, reflecting a reduction in pheomelanin pigment.
Interestingly, another Sox gene, Sox10, has been
implicated in pigmentation. Sox10 is expressed in neural crest cells as they migrate to numerous sites in the developing embryo
(21), and mutations in Sox10 result in, apart
from other things, hypopigmentation (4, 30, 35). One
population of neural crest cells is the melanoblasts, which migrate
through the mesenchymal layer beneath the ectoderm before populating
the dermis and differentiating to melanocytes. Melanocytes that
populate the hair bulb, adjacent to the dermal papilla, donate
melanosomes to the matrix keratinocytes, giving hair its visible pigmentation.
There is no evidence that migrating neural crest cells, which express
Sox10, also express Sox18. Cells that will give
rise to the dermal papilla, adjacent to the hair bulb, do, however, express Sox18, at least in a transient manner
(29). Perturbation of Sox18 function in
Ra and Sox18
/
mice does not
result in the hypopigmentation of hairs, though it does affect the
production of pheomelanin in hairs. This may be due to the effect
Sox18 mutations have on the agouti signaling peptide: cells
that express the agouti gene reside in the dermal papillae
(26). These are the same cell types as, or a population of
cells in close proximity to, those that express Sox18
transiently during hair follicle maturation. It is a distinct
possibility that normal Sox18 function is needed for
agouti-expressing cells to fulfill their role completely. It
seems unlikely that the receptor antagonized by the agouti signaling
peptide is adversely affected by Sox18 mutations, since in
Ra and Sox18
/
mice eumelanin is
produced by hair follicles, indicating that melanocyte-stimulating
hormone
and its receptor are functioning normally.
Binding site selection, analyses of chimeric proteins, and
phenotype rescue experiments indicate that there is scope for
redundancy amongst SOX proteins (18, 39). Other evidence for
functional redundancy includes the rescue of phenotypes by related SOX
proteins: mouse SOX2 can rescue the defects in the differentiation of
the midline glia caused by a mutation in the Drosophila gene
Dichaete (34). In addition, domains of different
SOX proteins may be interchanged with little change in function of the
chimeric protein; chimeric SOX1-SOX9 proteins displayed the ability to
activate transcription after binding the appropriate target sequences
(
-crystallin enhancer, DC5, for SOX1 and
Col2a1, enhancer, COL2C2, for SOX9), demonstrating that the
HMG box domains are interchangeable (17). Further,
functional redundancy has been documented amongst other developmentally
expressed gene families, such as the MyoD family (31) and Hox family (23). There is
some overlap in the expression of Sox7-, -17, and
-18 in the developing vascular endothelium (Jane Olsson,
personal communication), and it therefore remains a distinct
possibility given the mild phenotype of
Sox18
/
mice that there is functional
redundancy amongst SOX proteins. To address the question of redundancy
amongst these proteins, particularly subgroup F SOX proteins, the
relevant knockout mice, once available, can be used to generate double
and triple knockouts to test the hypothesis of functional redundancy.
Gene targeting in the mouse and identification of human mutations have revealed vital roles for SOX genes, with, in the cases of SOX9 and SOX10, both copies of the gene needed for normal development. This study provides the first evidence of a SOX gene that is largely dispensable for embryonic development. This study should contribute towards the understanding of possible interactions of SOX proteins in various embryonic tissues and the identification of downstream target genes.
| |
ACKNOWLEDGMENTS |
|---|
This work was funded by the National Heart Foundation (Australia), the Queensland Cancer Fund, and the National Health and Medical Research Council (Australia). P.K. is an Australian Research Council Senior Research Fellow.
We thank Anne Hardacre for invaluable help in the maintenance of the animal breeding colony and Philippe Soriano for the gift of the 129/Sv genomic library used for the production of the Sox18 targeting vector.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute for Molecular Bioscience, University of Queensland, Brisbane 4072, Australia. Phone: 61 7 3365 4491. Fax: 61 7 3365 4388. E-mail: p.koopman{at}cmcb.uq.edu.au.
Present address: Department of Cell Biology and Anatomy, Cornell
University Weill Medical College, New York, NY 10021.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abremski, K., and R. Hoess.
1984.
Bacteriophage P1 site-specific recombination. Purification and properties of the Cre recombinase protein.
J. Biol. Chem.
259:1509-1514 |
| 2. | Berta, P., J. R. Hawkins, A. H. Sinclair, A. Taylor, B. L. Griffiths, P. N. Goodfellow, and M. Fellous. 1990. Genetic evidence equating SRY and the male sex determining gene. Nature 348:448-450[CrossRef][Medline]. |
| 3. | Bi, W., J. M. Deng, Z. Zhang, R. R. Behringer, and B. de Crombrugghe. 1999. Sox9 is required for cartilage formation. Nat. Genet. 22:85-89[CrossRef][Medline]. |
| 4. |
Bondurand, N.,
K. Kuhlbrodt,
V. Pingault,
J. Enderich,
M. Sajus,
N. Tommerup,
M. Warburg,
R. C. Hennekam,
A. P. Read,
M. Wegner, and M. Goossens.
1999.
A molecular analysis of the Yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies.
Hum. Mol. Genet.
8:1785-1789 |
| 5. |
Carter, T. C., and R. J. S. Phillips.
1954.
Ragged, a semidominant coat texture mutant in the house mouse.
J. Hered.
45:151-154 |
| 6. | Collignon, J., S. Sockanathan, A. Hacker, M. Cohen-Tannoudji, D. Norris, S. Rastan, V. Episkopou, M. Stevanovic, P. N. Goodfellow, and R. Lovell-Badge. 1996. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 122:509-520[Abstract]. |
| 7. | Dry, F. W. 1926. The coat of the mouse (Mus musculus). J. Genet. 16:287-340. |
| 8. | Dunn, T. L., L. Mynett-Johnson, B. M. Hosking, P. A. Koopman, and G. E. O. Muscat. 1995. Sequence and expression of Sox-18, a new HMG-box transcription factor. Gene 161:223-225[CrossRef][Medline]. |
| 9. | Foster, J. W., M. A. Dominguez-Steglich, S. Guioli, C. Kwok, P. A. Weller, J. Weissenbach, S. Mansour, I. D. Young, P. N. Goodfellow, J. D. Brook, and A. J. Schafer. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530[CrossRef][Medline]. |
| 10. |
Green, E. L., and S. J. Mann.
1961.
Opossum, a semi-dominant lethal mutation affecting hair and other characteristics of mice.
J. Heredity
52:223-227 |
| 11. |
Harley, V. R.,
D. I. Jackson,
P. J. Hextall,
J. R. Hawkins,
G. D. Berkovitz,
S. Sockanathan,
R. Lovell-Badge, and P. N. Goodfellow.
1992.
DNA binding activity of recombinant SRY from normal males and XY females.
Science
255:453-456 |
| 12. |
Harley, V. R.,
R. Lovell-Badge, and P. N. Goodfellow.
1994.
Definition of a consensus DNA binding site for SRY.
Nucleic Acids Res.
22:1500-1501 |
| 13. | Hawkins, J. R., A. Taylor, P. Berta, J. Levilliers, B. Van der Auwera, and P. N. Goodfellow. 1992. Mutational analysis of SRY: nonsense and missense mutations in XY sex reversal. Hum. Genet. 88:471-474[CrossRef][Medline]. |
| 14. | Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 15. | Jäger, R. J., M. Anvret, K. Hall, and G. Scherer. 1990. A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature 348:452-454[CrossRef][Medline]. |
| 16. | Joyner, A. L. 1993. Gene targeting: a practical approach. Oxford University Press, Oxford, United Kingdom. |
| 17. |
Kamachi, Y.,
K. S. Cheah, and H. Kondoh.
1999.
Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9.
Mol. Cell. Biol.
19:107-120 |
| 18. | Kamachi, Y., M. Uchikawa, and H. Kondoh. 2000. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16:182-187[CrossRef][Medline]. |
| 19. | Korn, R., M. Schoor, H. Neuhaus, U. Henseling, R. Soininen, J. Zachgo, and A. Gossler. 1992. Enhancer trap integrations in mouse embryonic stem cells give rise to staining patterns in chimaeric embryos with a high frequency and detect endogenous genes. Mech. Dev. 39:95-109[CrossRef][Medline]. |
| 20. |
Kuhlbrodt, K.,
B. Herbarth,
E. Sock,
J. Enderich,
I. Hermans-Borgmeyer, and M. Wegner.
1998.
Cooperative function of POU proteins and SOX proteins in glial cells.
J. Biol. Chem.
273:16050-16057 |
| 21. |
Kuhlbrodt, K.,
B. Herbarth,
E. Sock,
I. Hermans-Borgmeyer, and M. Wegner.
1998.
Sox10, a novel transcriptional modulator in glial cells.
J. Neurosci.
18:237-250 |
| 22. | Lefebvre, V., P. Li, and B. de Crombrugghe. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17:5718-5733[CrossRef][Medline]. |
| 23. | Maconochie, M., S. Nonchev, A. Morrison, and R. Krumlauf. 1996. Paralogous Hox genes: function and regulation. Annu. Rev. Genet. 30:529-556[CrossRef][Medline]. |
| 24. | Mann, S. J. 1963. The phenogenetics of hair mutants in the house mouse: Opossum and Ragged. Genet. Res. 4:1-11. |
| 25. | Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352[CrossRef][Medline]. |
| 26. | Millar, S. E., M. W. Miller, M. E. Stevens, and G. S. Barsh. 1995. Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated. Development 121:3223-3232[Abstract]. |
| 27. |
Nagy, A.,
J. Rossant,
R. Nagy,
W. Abramow-Newerly, and J. C. Roder.
1993.
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Proc. Natl. Acad. Sci. USA
90:8424-8428 |
| 28. |
Nishiguchi, S.,
H. Wood,
H. Kondoh,
R. Lovell-Badge, and V. Episkopou.
1998.
Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice.
Genes Dev.
12:776-781 |
| 29. | Pennisi, D., J. Gardner, D. Chambers, B. Hosking, J. Peters, G. Muscat, C. Abbott, and P. Koopman. 2000. Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat. Genet. 24:434-437[CrossRef][Medline]. |
| 30. | Pingault, V., N. Bondurand, K. Kuhlbrodt, D. E. Goerich, M. O. Prehu, A. Puliti, B. Herbarth, I. Hermans-Borgmeyer, E. Legius, G. Matthijs, J. Amiel, S. Lyonnet, I. Ceccherini, G. Romeo, J. C. Smith, A. P. Read, M. Wegner, and M. Goossens. 1998. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet. 18:171-173[CrossRef][Medline]. |
| 31. | Rudnicki, M. A., and R. Jaenisch. 1995. The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17:203-209[CrossRef][Medline]. |
| 32. | Schilham, M. W., M. A. Oosterwegel, P. Moerer, J. Ya, P. A. J. de Boer, M. van de Wetering, S. Verbeek, W. H. Lamers, A. M. Kruisbeek, A. Cumano, and H. Clevers. 1996. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380:711-714[CrossRef][Medline]. |
| 33. |
Slee, J.
1957.
The morphology and development of ragged a mutant affecting the skin and hair of the house mouse. I. Adult morphology.
J. Genet.
55:100-121.
|
| 34. | Soriano, N. S., and S. Russell. 1998. The Drosophila SOX-domain protein Dichaete is required for the development of the central nervous system midline. Development 125:3989-3996[Abstract]. |
| 35. | Southard-Smith, E. M., L. Kos, and W. J. Pavan. 1998. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 18:60-64[CrossRef][Medline]. |
| 36. | Stock, D. W., A. V. Buchanan, Z. Zhao, and K. M. Weiss. 1996. Numerous members of the Sox family of HMG box-containing genes are expressed in developing mouse teeth. Genomics 37:234-237[CrossRef][Medline]. |
| 37. | Uwanogho, D., M. Rex, E. J. Cartwright, G. Pearl, C. Healy, P. Scotting, and P. T. Sharpe. 1994. Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an interactive role in neural development. Mech. Dev. 49:23-36. |
| 38. | Wagner, T., J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F. D. Bricarelli, J. Keutel, E. Hustert, U. Wolf, N. Tommerup, W. Schempp, and G. Scherer. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120[CrossRef][Medline]. |
| 39. |
Wegner, M.
1999.
From head to toes: the multiple facets of Sox proteins.
Nucleic Acids Res.
27:1409-1420 |
| 40. | Wheatley, S. C., C. M. Isacke, and P. H. Crossley. 1993. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 119:295-306[Abstract]. |
| 41. | Wood, S. A., N. D. Allen, J. Rossant, A. Auerbach, and A. Nagy. 1993. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature 365:87-89[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»